Jared Holz, Mizuho, joins 'Fast Money' to talk how to play Eli Lilly's stock right now. CFPB sues Capital One for 'cheating' ...

Sean Darby of Mizuho Securities discusses China's tricky balancing act as it deals with a weakening yuan, and why this will ...

This S&P 500 component has a market capitalization of $54.81 billion. Shares can be purchased at a 19% discount from book.

With an average consensus target price 33% higher than its current $190 stock price, Onto Innovation is deemed a compelling ...

Retail traders who had developed a taste for gambling on speculative stocks were facing a day of reckoning on Wednesday as ...

U.S. stock futures leaned lower Friday on concern over possible export restrictions on Nvidia, ahead of key data on the jobs ...

Mizuho analyst Uy Ear says that while Biogen’s (BIIB) offer for Sage Therapeutics (SAGE) is a 30% premium to Sage’s Friday’s closing price, ...

Less than two months after scoring what analysts deemed a "best-case" FDA approval for its cardiomyopathy drug Attruby, ...

Mizuho analysts slashed their price target on Intel Corporation ( INTC, Financial) stock on Friday, sending the chipmaker to ...

We recently compiled a list of the 10 Best Bank Penny Stocks to Buy According to Hedge Funds. In this article, we are going ...

Investors may view longer Treasury yields hovering around 5% as a buying opportunity, given years of low rates in the wake of the 2007 to 2008 crisis. Yet "the bond market has not taken on board" the ...

Mizuho has unveiled its January US Top Picks, spotlighting Chewy, GE Vernova, Enliven Therapeutics, Quest Diagnostics, DuPont ...